1. Home
  2. ZS vs GEHC Comparison

ZS vs GEHC Comparison

Compare ZS & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zscaler Inc.

ZS

Zscaler Inc.

HOLD

Current Price

$186.30

Market Cap

35.1B

Sector

Technology

ML Signal

HOLD

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

HOLD

Current Price

$83.08

Market Cap

38.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZS
GEHC
Founded
2007
1892
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Computer Software: Prepackaged Software
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
35.1B
38.9B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ZS
GEHC
Price
$186.30
$83.08
Analyst Decision
Buy
Buy
Analyst Count
34
12
Target Price
$318.42
$88.75
AVG Volume (30 Days)
1.9M
3.5M
Earning Date
03-04-2026
02-04-2026
Dividend Yield
N/A
0.18%
EPS Growth
N/A
32.35
EPS
N/A
4.83
Revenue
$2,833,272,000.00
$20,246,000,000.00
Revenue This Year
$27.01
$6.42
Revenue Next Year
$19.32
$4.34
P/E Ratio
N/A
$16.31
Revenue Growth
23.24
3.51
52 Week Low
$164.78
$57.65
52 Week High
$336.99
$94.80

Technical Indicators

Market Signals
Indicator
ZS
GEHC
Relative Strength Index (RSI) 25.09 53.47
Support Level $197.47 $78.23
Resistance Level $229.00 $83.21
Average True Range (ATR) 7.50 2.10
MACD -1.22 -0.14
Stochastic Oscillator 15.99 63.79

Price Performance

Historical Comparison
ZS
GEHC

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: